BFRI Biofrontera Inc

USD 0.94 -0.06 ( -6.39)%
Icon

Biofrontera Inc (BFRI) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.94

-0.06 (-6.39)%

USD 7.68M

0.30M

USD 7.00(+647.78%)

USD 4.50 (+380.72%)

Icon

BFRI

Biofrontera Inc (USD)
COMMON STOCK | NSD
USD 0.94
-0.06 ( -6.39)%
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 7.68M

USD 4.50 (+380.72%)

USD 0.94

Biofrontera Inc (BFRI) Stock Forecast

USD 7.00
(+647.78%)

Based on the Biofrontera Inc stock forecast from 1 analysts, the average analyst target price for Biofrontera Inc is USD 7.00 over the next 12 months. Biofrontera Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Biofrontera Inc is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Biofrontera Inc’s stock price was USD 0.94. Biofrontera Inc’s stock price has changed by -8.23% over the past week, -14.12% over the past month and -75.04% over the last year.

No recent analyst target price found for Biofrontera Inc
No recent average analyst rating found for Biofrontera Inc

Company Overview Biofrontera Inc

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin les...Read More

120 Presidential Way, Woburn, MA, United States, 01801

83

December

USD

USA

Adjusted Closing Price for Biofrontera Inc (BFRI)

Loading...

Unadjusted Closing Price for Biofrontera Inc (BFRI)

Loading...

Share Trading Volume for Biofrontera Inc Shares

Loading...

Compare Performance of Biofrontera Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BFRI

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Biofrontera Inc (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VTRS
Viatris Inc -0.20 (-1.52%) USD15.96B 225.00 12.42

Frequently Asked Questions About Biofrontera Inc (BFRI) Stock

Based on ratings from 1 analysts Biofrontera Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 1 buy, sell and hold ratings.

Unfortunately we do not have enough data on BFRI's stock to indicate if its a good dividend stock.

Based on targets from 1 analysts, the average taret price for BFRI is USD 7.00 over the next 12 months. The maximum analyst target price is USD 7 while the minimum anlayst target price is USD 7.

BFRI stock's Price/Earning ratio is 0.78. Our analysis grades BFRI stock's Price / Earning ratio at B. This means that BFRI stock's Price/Earning ratio is above 14% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSD exchange. Based on this BFRI may be undervalued for its sector.

The last closing price of BFRI's stock was USD 0.94.

The most recent market capitalization for BFRI is USD 7.68M.

Based on targets from 1 analysts, the average taret price for BFRI is projected at USD 7.00 over the next 12 months. This means that BFRI's stock price may go up by +647.78% over the next 12 months.

We can't find any ETFs which contains Biofrontera Inc's stock.

As per our most recent records Biofrontera Inc has 83 Employees.

Biofrontera Inc's registered address is 120 Presidential Way, Woburn, MA, United States, 01801. You can get more information about it from Biofrontera Inc's website at https://www.biofrontera-us.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About Biofrontera Inc (BFRI) Stock

Based on ratings from 1 analysts Biofrontera Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 1 buy, sell and hold ratings.

Unfortunately we do not have enough data on BFRI's stock to indicate if its a good dividend stock.

Based on targets from 1 analysts, the average taret price for BFRI is USD 7.00 over the next 12 months. The maximum analyst target price is USD 7 while the minimum anlayst target price is USD 7.

BFRI stock's Price/Earning ratio is 0.78. Our analysis grades BFRI stock's Price / Earning ratio at B. This means that BFRI stock's Price/Earning ratio is above 14% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSD exchange. Based on this BFRI may be undervalued for its sector.

The last closing price of BFRI's stock was USD 0.94.

The most recent market capitalization for BFRI is USD 7.68M.

Based on targets from 1 analysts, the average taret price for BFRI is projected at USD 7.00 over the next 12 months. This means that BFRI's stock price may go up by +647.78% over the next 12 months.

We can't find any ETFs which contains Biofrontera Inc's stock.

As per our most recent records Biofrontera Inc has 83 Employees.

Biofrontera Inc's registered address is 120 Presidential Way, Woburn, MA, United States, 01801. You can get more information about it from Biofrontera Inc's website at https://www.biofrontera-us.com.
Loading...